 | • レポートコード：GIR-22F19261 • 出版社/出版日：GlobalInfoResearch / 2022年11月 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Dermatological Disorders Medications Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社の最新の調査によると、世界の皮膚疾患治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 皮膚疾患治療薬市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次をカバーします。 ・処方薬、一般用医薬品 アプリケーション別セグメントは次のように区分されます。 ・病院薬局、オンライン薬局、リテール薬局 世界の皮膚疾患治療薬市場の主要な市場プレーヤーは以下のとおりです。 ・Mylan Pharmaceuticals、Pfizer、Roche、Almirall、Bausch Health、Barrier Therapeutics、PharmaDerm、Bristol-Myers Squibb、Galderma、GlaxoSmithKline、Novartis、Sinclair Pharma 地域別セグメントは次の地域・国をカバーします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、皮膚疾患治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な皮膚疾患治療薬メーカーの企業概要、2019年～2022年までの皮膚疾患治療薬の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な皮膚疾患治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別皮膚疾患治療薬の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの皮膚疾患治療薬のタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での皮膚疾患治療薬市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および皮膚疾患治療薬の産業チェーンを掲載しています。 ・第13、14、15章では、皮膚疾患治療薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - 皮膚疾患治療薬の概要 - タイプ別分析（2017年vs2021年vs2028年）：処方薬、一般用医薬品 - アプリケーション別分析（2017年vs2021年vs2028年）：病院薬局、オンライン薬局、リテール薬局 - 世界の皮膚疾患治療薬市場規模・予測 - 世界の皮膚疾患治療薬生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Mylan Pharmaceuticals、Pfizer、Roche、Almirall、Bausch Health、Barrier Therapeutics、PharmaDerm、Bristol-Myers Squibb、Galderma、GlaxoSmithKline、Novartis、Sinclair Pharma ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：処方薬、一般用医薬品 ・アプリケーション別分析2017年-2028年：病院薬局、オンライン薬局、リテール薬局 ・皮膚疾患治療薬の北米市場分析 - 皮膚疾患治療薬の北米市場：タイプ別市場規模2017年-2028年 - 皮膚疾患治療薬の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・皮膚疾患治療薬のヨーロッパ市場分析 - ：皮膚疾患治療薬のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：皮膚疾患治療薬のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・皮膚疾患治療薬のアジア太平洋市場分析 - 皮膚疾患治療薬のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 皮膚疾患治療薬のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・皮膚疾患治療薬の南米市場分析 - 皮膚疾患治療薬の南米市場：タイプ別市場規模2017年-2028年 - 皮膚疾患治療薬の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・皮膚疾患治療薬の中東・アフリカ市場分析 - 皮膚疾患治療薬の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 皮膚疾患治療薬の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Dermatological Disorders Medications market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Dermatological Disorders Medications market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital Pharmacies accounting for % of the Dermatological Disorders Medications global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Prescription Drugs segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Dermatological Disorders Medications include Mylan Pharmaceuticals, Pfizer, Roche, Almirall, and Bausch Health, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Dermatological Disorders Medications market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Prescription Drugs
Over-The-Counter Drugs
Market segment by Application can be divided into
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
The key market players for global Dermatological Disorders Medications market are listed below:
Mylan Pharmaceuticals
Pfizer
Roche
Almirall
Bausch Health
Barrier Therapeutics
PharmaDerm
Bristol-Myers Squibb
Galderma
GlaxoSmithKline
Novartis
Sinclair Pharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dermatological Disorders Medications product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dermatological Disorders Medications, with price, sales, revenue and global market share of Dermatological Disorders Medications from 2019 to 2022.
Chapter 3, the Dermatological Disorders Medications competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dermatological Disorders Medications breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Dermatological Disorders Medications market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Dermatological Disorders Medications.
Chapter 13, 14, and 15, to describe Dermatological Disorders Medications sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Dermatological Disorders Medications Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Dermatological Disorders Medications Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Prescription Drugs
1.2.3 Over-The-Counter Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Dermatological Disorders Medications Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Global Dermatological Disorders Medications Market Size & Forecast
1.4.1 Global Dermatological Disorders Medications Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Dermatological Disorders Medications Sales in Volume (2017-2028)
1.4.3 Global Dermatological Disorders Medications Price (2017-2028)
1.5 Global Dermatological Disorders Medications Production Capacity Analysis
1.5.1 Global Dermatological Disorders Medications Total Production Capacity (2017-2028)
1.5.2 Global Dermatological Disorders Medications Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Dermatological Disorders Medications Market Drivers
1.6.2 Dermatological Disorders Medications Market Restraints
1.6.3 Dermatological Disorders Medications Trends Analysis
2 Manufacturers Profiles
2.1 Mylan Pharmaceuticals
2.1.1 Mylan Pharmaceuticals Details
2.1.2 Mylan Pharmaceuticals Major Business
2.1.3 Mylan Pharmaceuticals Dermatological Disorders Medications Product and Services
2.1.4 Mylan Pharmaceuticals Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Dermatological Disorders Medications Product and Services
2.2.4 Pfizer Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Dermatological Disorders Medications Product and Services
2.3.4 Roche Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Almirall
2.4.1 Almirall Details
2.4.2 Almirall Major Business
2.4.3 Almirall Dermatological Disorders Medications Product and Services
2.4.4 Almirall Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Bausch Health
2.5.1 Bausch Health Details
2.5.2 Bausch Health Major Business
2.5.3 Bausch Health Dermatological Disorders Medications Product and Services
2.5.4 Bausch Health Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Barrier Therapeutics
2.6.1 Barrier Therapeutics Details
2.6.2 Barrier Therapeutics Major Business
2.6.3 Barrier Therapeutics Dermatological Disorders Medications Product and Services
2.6.4 Barrier Therapeutics Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 PharmaDerm
2.7.1 PharmaDerm Details
2.7.2 PharmaDerm Major Business
2.7.3 PharmaDerm Dermatological Disorders Medications Product and Services
2.7.4 PharmaDerm Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Bristol-Myers Squibb
2.8.1 Bristol-Myers Squibb Details
2.8.2 Bristol-Myers Squibb Major Business
2.8.3 Bristol-Myers Squibb Dermatological Disorders Medications Product and Services
2.8.4 Bristol-Myers Squibb Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Galderma
2.9.1 Galderma Details
2.9.2 Galderma Major Business
2.9.3 Galderma Dermatological Disorders Medications Product and Services
2.9.4 Galderma Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 GlaxoSmithKline
2.10.1 GlaxoSmithKline Details
2.10.2 GlaxoSmithKline Major Business
2.10.3 GlaxoSmithKline Dermatological Disorders Medications Product and Services
2.10.4 GlaxoSmithKline Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Novartis
2.11.1 Novartis Details
2.11.2 Novartis Major Business
2.11.3 Novartis Dermatological Disorders Medications Product and Services
2.11.4 Novartis Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Sinclair Pharma
2.12.1 Sinclair Pharma Details
2.12.2 Sinclair Pharma Major Business
2.12.3 Sinclair Pharma Dermatological Disorders Medications Product and Services
2.12.4 Sinclair Pharma Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Dermatological Disorders Medications Breakdown Data by Manufacturer
3.1 Global Dermatological Disorders Medications Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Dermatological Disorders Medications Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Dermatological Disorders Medications
3.4 Market Concentration Rate
3.4.1 Top 3 Dermatological Disorders Medications Manufacturer Market Share in 2021
3.4.2 Top 6 Dermatological Disorders Medications Manufacturer Market Share in 2021
3.5 Global Dermatological Disorders Medications Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Dermatological Disorders Medications Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Dermatological Disorders Medications Market Size by Region
4.1.1 Global Dermatological Disorders Medications Sales in Volume by Region (2017-2028)
4.1.2 Global Dermatological Disorders Medications Revenue by Region (2017-2028)
4.2 North America Dermatological Disorders Medications Revenue (2017-2028)
4.3 Europe Dermatological Disorders Medications Revenue (2017-2028)
4.4 Asia-Pacific Dermatological Disorders Medications Revenue (2017-2028)
4.5 South America Dermatological Disorders Medications Revenue (2017-2028)
4.6 Middle East and Africa Dermatological Disorders Medications Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Dermatological Disorders Medications Sales in Volume by Type (2017-2028)
5.2 Global Dermatological Disorders Medications Revenue by Type (2017-2028)
5.3 Global Dermatological Disorders Medications Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Dermatological Disorders Medications Sales in Volume by Application (2017-2028)
6.2 Global Dermatological Disorders Medications Revenue by Application (2017-2028)
6.3 Global Dermatological Disorders Medications Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Dermatological Disorders Medications Sales by Type (2017-2028)
7.2 North America Dermatological Disorders Medications Sales by Application (2017-2028)
7.3 North America Dermatological Disorders Medications Market Size by Country
7.3.1 North America Dermatological Disorders Medications Sales in Volume by Country (2017-2028)
7.3.2 North America Dermatological Disorders Medications Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Dermatological Disorders Medications Sales by Type (2017-2028)
8.2 Europe Dermatological Disorders Medications Sales by Application (2017-2028)
8.3 Europe Dermatological Disorders Medications Market Size by Country
8.3.1 Europe Dermatological Disorders Medications Sales in Volume by Country (2017-2028)
8.3.2 Europe Dermatological Disorders Medications Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Dermatological Disorders Medications Sales by Type (2017-2028)
9.2 Asia-Pacific Dermatological Disorders Medications Sales by Application (2017-2028)
9.3 Asia-Pacific Dermatological Disorders Medications Market Size by Region
9.3.1 Asia-Pacific Dermatological Disorders Medications Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Dermatological Disorders Medications Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Dermatological Disorders Medications Sales by Type (2017-2028)
10.2 South America Dermatological Disorders Medications Sales by Application (2017-2028)
10.3 South America Dermatological Disorders Medications Market Size by Country
10.3.1 South America Dermatological Disorders Medications Sales in Volume by Country (2017-2028)
10.3.2 South America Dermatological Disorders Medications Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Dermatological Disorders Medications Sales by Type (2017-2028)
11.2 Middle East & Africa Dermatological Disorders Medications Sales by Application (2017-2028)
11.3 Middle East & Africa Dermatological Disorders Medications Market Size by Country
11.3.1 Middle East & Africa Dermatological Disorders Medications Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Dermatological Disorders Medications Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Dermatological Disorders Medications and Key Manufacturers
12.2 Manufacturing Costs Percentage of Dermatological Disorders Medications
12.3 Dermatological Disorders Medications Production Process
12.4 Dermatological Disorders Medications Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Dermatological Disorders Medications Typical Distributors
13.3 Dermatological Disorders Medications Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer